AR and diabetes mellitus: Testosterone synthesis has been reported to be reduced in patients with diabetes [20], but continued androgen receptor (AR) activation in the presence of low circulating levels of testosterone have been proposed, indicating alternative AR ligands to bypass the testosterone/dihydrotestosterone-mediated AR activation [10].